Candel Therapeutics, Inc.CADLNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+10.8%
5Y CAGR+27.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+10.8%/yr
Annual compound
5Y CAGR
+27.8%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $47.42M | +46.4% |
| 2024 | $32.38M | +124.7% |
| 2023 | $14.41M | -58.6% |
| 2022 | $34.85M | +209.6% |
| 2021 | $11.26M | -19.2% |
| 2020 | $13.94M | +445.4% |
| 2019 | $2.56M | - |